DCPG
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
4-[(1S)-1-amino-2-hydroxy-2-oxoethyl]phthalic acid
|
|
Identifiers | |
CAS Number | 201730-11-2 |
PubChem | CID: 16062593 |
IUPHAR/BPS | 1407 |
ChemSpider | 17222214 |
Chemical data | |
Formula | C10H9NO6 |
Molecular mass | 239.181 g/mol |
|
|
|
|
(what is this?) (verify) |
DCPG ((S)-3,4-DCPG) is a drug used in scientific research, which acts as a potent and subtype-selective agonist for the metabotropic glutamate receptor mGluR8. It has anticonvulsant effects in animal studies,[1][2] and has also been investigated as a possible treatment for hyperalgesia.[3]
References
- ↑ Moldrich RX, Chapman AG, De Sarro G, Meldrum BS. Glutamate metabotropic receptors as targets for drug therapy in epilepsy. European Journal of Pharmacology. 2003 Aug 22;476(1-2):3-16. doi:10.1016/S0014-2999(03)02149-6 PMID 12969743
- ↑ Folbergrová J, Druga R, Haugvicová R, Mares P, Otáhal J. Anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid. Neuropharmacology. 2008 Mar;54(4):665-75. PMID 18191956
- ↑ Marabese I, de Novellis V, Palazzo E, Scafuro MA, Vita D, Rossi F, Maione S. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice. Neuropharmacology. 2007 Feb;52(2):253-62. PMID 17113112
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Anticonvulsants
- Amino acid derivatives
- Tricarboxylic acids
- MGlu8 receptor agonists
- Anticonvulsant stubs